Enhertu Approved for Any HER2-Positive Solid Cancer
Could 3, 2024, by Carmen Phillips With FDA's expanded approval of trastuzumab deruxtecan (Enhertu), the HER2-targeted drug can now be ...
Tag: HER2Positive
FDA Approves Enhertu for Some With HER2-Positive Solid Tumors
The FDA permitted Enhertu for some sufferers with HER2-positive stable tumors who don't have different various therapies.The Meals and Drug ...
Changes to Treatment for HER2-Positive Gastric Cancer
November 17, 2023, by Carmen Phillips Remedy for HER2-positive abdomen and gastroesophageal junction cancers is predicted to vary primarily based ...
Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib
Credit score: Unsplash/CC0 Public Area Sufferers with HER2-positive breast most cancers that has began to unfold to different components of ...
Tucatinib Approved for HER2-Positive Colorectal Cancer
February 10, 2023, by Sharon Reynolds Tucatinib (Tukysa) and trastuzumab (Herceptin) at the moment are permitted by FDA to deal ...
